August 20, 2017 9:27 PM ET


Company Overview of SteadyMed Therapeutics, Inc.

Company Overview

SteadyMed Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes therapeutic product candidates. The company provides PatchPump, a customizable, pre-filled, and pre-programmed disposable parenteral delivery platform for large volume and viscous formulations. It offers Trevyent, a single-use PatchPump that is pre-filled with treprostinil and pre-programed at the correct delivery rate; SMT-201 for subcutaneous delivery of Ketorolac, a non-steroidal anti-inflammatory drug; and SMT-301 to deliver bupivacaine, a local anesthetic directly into the surgical wound area to provide local pain relief. The company was founded in 2005 and is based in San Ramon, California wit...

2603 Camino Ramon

Suite 350

San Ramon, CA 94583

United States

Founded in 2005



Key Executives for SteadyMed Therapeutics, Inc.

Chief Executive Officer, President and Director
Age: 49
Co-Founder and Director
Chief Financial Officer and Executive Vice President
Age: 63
Vice President of Operations
Compensation as of Fiscal Year 2017.

SteadyMed Therapeutics, Inc. Key Developments

SteadyMed Therapeutics Announces Successful Completion of Clinical Study of Trevyent

SteadyMed Therapeutics announced the successful completion of a clinical study of Trevyent. SteadyMed's clinical validation study enrolled 60 healthy adult volunteers in an in-clinic setting designed to examine the performance of the PatchPump used by Trevyent. Each trial subject was provided one PatchPump device containing a placebo formulation and each otherwise carried on with their normal daily and nighttime routines over a 48 hour period. The goals of the study were to evaluate the safety and performance functions of the PatchPump delivery system as well as the tolerability of the on-body application of the product. According to SteadyMed, the results "indicate that the PatchPump devices performed as intended in all categories of evaluation", including dose accuracy and precision.

SteadyMed Therapeutics Ltd. Hires Carl Hicks as Vice President of PH Patient Advocacy and Community Relations

SteadyMed Therapeutics Ltd. announced that it has hired Carl Hicks, in a newly created role of Vice President of PH Patient Advocacy and Community Relations. Hicks joins the company from the Pulmonary Hypertension Association where he served in a number of roles including Executive Vice President, Chairman of the Board and Board member since 2000.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SteadyMed Therapeutics, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at